NERVGEN PHARMA CORP. (NGEN) AI Dilution Summary

NervGen held cash of $86,789,698 at 2026-06-30, against estimated monthly burn of $2,322,040. Its most recent capital raise was a registered public offering that closed 2026-05-22: $60,000,000 gross for 24,000,000 shares at $2.50. After the balance-sheet date, stock option exercises brought in $1,977,550 net (dated 2026-08-13).